Identification, validation, and characterization of approved and investigational drugs interfering with the <scp>SARS</scp>‐<scp>CoV</scp>‐2 endoribonuclease Nsp15
- DOI
- 10.1002/pro.70156
- Published
- 2025-05-15
- Container
- Protein Science
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/pro.70156,
title = {Identification, validation, and characterization of approved and investigational drugs interfering with the <scp>SARS</scp>‐<scp>CoV</scp>‐2 endoribonuclease Nsp15},
author = {Spyros D. Chatziefthymiou and Maria Kuzikov and Sara Afandi and Greta Kovacs and Sukrit Srivastava and Andrea Zaliani and Andrey Gruzinov and Guillaume Pompidor and Michele Lunelli and Golam Rizvee Ahmed and Jörg Labahn and Johanna Hakanpää and Björn Windshügel and Michael Kolbe},
year = {2025},
journal = {Protein Science},
doi = {10.1002/pro.70156},
url = {https://doi.org/10.1002/pro.70156}
}RIS
TY - JOUR TI - Identification, validation, and characterization of approved and investigational drugs interfering with the <scp>SARS</scp>‐<scp>CoV</scp>‐2 endoribonuclease Nsp15 AU - Spyros D. Chatziefthymiou AU - Maria Kuzikov AU - Sara Afandi AU - Greta Kovacs AU - Sukrit Srivastava AU - Andrea Zaliani AU - Andrey Gruzinov AU - Guillaume Pompidor AU - Michele Lunelli AU - Golam Rizvee Ahmed AU - Jörg Labahn AU - Johanna Hakanpää AU - Björn Windshügel AU - Michael Kolbe PY - 2025 JO - Protein Science DO - 10.1002/pro.70156 UR - https://doi.org/10.1002/pro.70156 ER -
APA
Chatziefthymiou, S. D., Kuzikov, M., Afandi, S., Kovacs, G., Srivastava, S., Zaliani, A., Gruzinov, A., Pompidor, G., Lunelli, M., Ahmed, G. R., Labahn, J., Hakanpää, J., Windshügel, B., & Kolbe, M. (2025). Identification, validation, and characterization of approved and investigational drugs interfering with the <scp>SARS</scp>‐<scp>CoV</scp>‐2 endoribonuclease Nsp15. Protein Science. https://doi.org/10.1002/pro.70156
Source records
- crossref · retrieved 2026-09-27T08:27:59.550Z